BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12948256)

  • 61. Ethambutol optic neuropathy associated with enhancement at the optic chiasm.
    Lu PG; Kung NH; Van Stavern GP
    Can J Ophthalmol; 2017 Oct; 52(5):e178-e181. PubMed ID: 28985827
    [No Abstract]   [Full Text] [Related]  

  • 62. The rare ethambutol-induced optic neuropathy: A case-report and literature review.
    Song W; Si S
    Medicine (Baltimore); 2017 Jan; 96(2):e5889. PubMed ID: 28079833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy.
    Salmon JF; Carmichael TR; Welsh NH
    Br J Ophthalmol; 1987 Mar; 71(3):192-6. PubMed ID: 3828274
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
    Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polazek E; Rykowska Z; Frenkel A
    Gruzlica; 1969 Jul; 37(7):659-68. PubMed ID: 5350928
    [No Abstract]   [Full Text] [Related]  

  • 65. Characterizing ethambutol-induced optic neuropathy with a 3D computer-automated threshold Amsler grid test.
    Kim JK; Fahimi A; Fink W; Nazemi PP; Nguyen D; Sadun AA
    Clin Exp Ophthalmol; 2008 Jul; 36(5):484-8. PubMed ID: 18925920
    [No Abstract]   [Full Text] [Related]  

  • 66. Serum copper (cu) alterations in pulmonary tuberculosis patients under treatment with ethambutol.
    Abbasi Nazari M; Kobarfard F; Tabarsi P; Salamzadeh J
    Biol Trace Elem Res; 2009 May; 128(2):161-6. PubMed ID: 19002388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical assessment of ethambutol].
    Rybaczewski SK
    Gruzlica; 1970 Apr; 38(4):305-11. PubMed ID: 5453040
    [No Abstract]   [Full Text] [Related]  

  • 68. Ethambutol-induced optic neuropathy.
    Kyncl M; Fus M; Lestak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):288-293. PubMed ID: 35582729
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Ethambutol-induced toxic optic neuropathy during treatment of tuberculosis meningitis in a child].
    Krichene MA; Hassina S; Mrad K; Hasnaoui I; Serghini L; Abdallah E; Berraho HA
    J Fr Ophtalmol; 2023 Jun; 46(6):658-661. PubMed ID: 37208267
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Optic injury by ethambutol and its prophylaxis and treatment].
    Liang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):444-5. PubMed ID: 11778511
    [No Abstract]   [Full Text] [Related]  

  • 71. Optic neuropathy associated with ethambutol in Koreans.
    Choi SY; Hwang JM
    Korean J Ophthalmol; 1997 Dec; 11(2):106-10. PubMed ID: 9510653
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Present status of ethambutol-induced optic neuropathy].
    Wang W; Yang H; Xhang XL
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):184-8. PubMed ID: 22558642
    [TBL] [Abstract][Full Text] [Related]  

  • 73. "Neuroimaging in ethambutol induced optic neuropathy: MRI in time can save the vision".
    Murumkar VS; Biswas S; Saini JS; Prabhuraj AR
    Indian J Tuberc; 2021 Jul; 68(3):408-411. PubMed ID: 34099211
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ethambutol-induced optic neuropathy: Functional and structural changes in the retina and optic nerve.
    Sen S; Mandal S; Banerjee M; Gk R; Saxena A; Aalok SP; Saxena R
    Semin Ophthalmol; 2022 Aug; 37(6):730-739. PubMed ID: 35699333
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Computerized perimetry in infants treated with ethambutol (author's transl)].
    Gramer E; Jeschke R; Krieglstein GK
    Klin Padiatr; 1982 Jan; 194(1):52-5. PubMed ID: 6977676
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ethambutol dosage for the treatment of children: literature review and recommendations.
    Donald PR; Maher D; Maritz JS; Qazi S
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1318-30. PubMed ID: 17167947
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Disentangling renal function in the context of irreversible ethambutol optic neuropathy.
    Chatziralli IP; Papazisis L; Keryttopoulos P; Papadopoulou D; Sergentanis TN
    Int Ophthalmol; 2010 Dec; 30(6):743-4. PubMed ID: 20111890
    [No Abstract]   [Full Text] [Related]  

  • 79. Ethambutol-induced toxic epidermal necrolysis.
    Chaudhary SC; Atam V; Gupta A; Arya R; Soni D
    J Assoc Physicians India; 2011 Jun; 59():391-2. PubMed ID: 21751601
    [No Abstract]   [Full Text] [Related]  

  • 80. [Ethambutol, alone and in association, in the therapy of pulmonary tuberculosis. Preliminary clinical note].
    Spina G; Mauro G; Corniola G; Cinquanta B
    Minerva Med; 1967 Sep; 58(75):3192-209. PubMed ID: 6048041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.